Psychosocial Distress of Patients with Psoriasis: Protocol for an Assessment of Care Needs and the Development of a Supportive Intervention

Overview

Journal JMIR Res Protoc

Publisher JMIR Publications

Specialty General Medicine

Date 2018 Feb 9

PMID 29415875

Citations 9

Authors

Jordis Maria Zill

Jorg Dirmaier

Matthias Augustin

Sarah Dwinger

Eva Christalle

Martin Harter

Ulrich Mrowietz

Affiliations

Soon will be listed here.

Abstract

Background: Psoriasis is a chronic inflammatory disease that is often associated with a number of somatic and mental comorbidity. Patients with psoriasis show an increased risk of depression and (social) anxiety.

Objective: The aims of this study are 1) to explore the psychosocial distress of patients with psoriasis and to assess their care needs; and 2) to develop a supportive intervention based on the prior results.

Methods: A multi-stage design with four phases combining quantitative and qualitative methodology will be used and conducted in two centers. 1) A scoping review and focus groups will be used to design a questionnaire to assess the psychosocial distress and care needs of the patients. 2) The questionnaire developed in phase 1 will be used in a cross-sectional survey to assess the extent of psychosocial distress and supportive care needs in 400 patients with psoriasis. 3) A systematic review and meta-analysis will be conducted to identify psychosocial and psychoeducational interventions for patients with psoriasis and to describe their effectiveness. 4) Based on the results of the phases 2 and 3 a manualized supportive intervention will be developed and the feasibility and acceptance of the intervention will be assessed.

Results: Currently, phase 1 of the project has been completed and the recruitment for phase 2 has been started. The systematic review and meta-analysis of phase 3 are conducted simultaneously to phase 2 and results are expected soon. Phase 4 has not been started yet.

Conclusions: The expected results of this study will show the extent of psychosocial distress of patients with psoriasis in Germany and supplement previous research with findings about the supportive care needs of this patient group. Moreover, the developed intervention will help to address the psychosocial support needs of patients with psoriasis. Research shows that psychosocial support is strongly needed.

Citing Articles

Reaction to Disease and Coping Strategies in Stressful Situations among Psoriasis Patients: Cross-Sectional Study.

Kowalewska B, Milewska-Buzun M, Cybulski M, Szpakow A, Khvorik D, Sobolewski M J Clin Med. 2024; 13(16).

PMID: 39200835 PMC: 11355611. DOI: 10.3390/jcm13164693.

Association of psoriasis and periodontitis in the north Indian population.

Sachan S, Trivedi S, Sharma S J Oral Biol Craniofac Res. 2024; 14(5):507-511.

PMID: 39050524 PMC: 11268335. DOI: 10.1016/j.jobcr.2024.06.008.

Contribution of the Environment, Epigenetic Mechanisms and Non-Coding RNAs in Psoriasis.

Antonatos C, Grafanaki K, Asmenoudi P, Xiropotamos P, Nani P, Georgakilas G Biomedicines. 2022; 10(8).

PMID: 36009480 PMC: 9405550. DOI: 10.3390/biomedicines10081934.

The Impact of Stress-Coping Strategies and the Severity of Psoriasis on Self-Esteem, Illness Acceptance and Life Satisfaction.

Kowalewska B, Krajewska-Kulak E, Sobolewski M Dermatol Ther (Heidelb). 2022; 12(2):529-543.

PMID: 35041156 PMC: 8764316. DOI: 10.1007/s13555-021-00669-8.

Skin-Disease Specific and Generic Psychometric Measures in Patients with Psoriasis.

Kowalewska B, Jankowiak B, Krajewska-Kulak E, Milewski R, Sobolewski M Dermatol Ther (Heidelb). 2021; 11(6):1999-2015.

PMID: 34585342 PMC: 8478271. DOI: 10.1007/s13555-021-00609-6.

References

Kroenke K, Spitzer R, Williams J . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606-13. PMC: 1495268. DOI: 10.1046/j.1525-1497.2001.016009606.x. View

Levac D, Colquhoun H, OBrien K . Scoping studies: advancing the methodology. Implement Sci. 2010; 5:69. PMC: 2954944. DOI: 10.1186/1748-5908-5-69. View

Eskin M, Savk E, Uslu M, Kucukaydogan N . Social problem-solving, perceived stress, negative life events, depression and life satisfaction in psoriasis. J Eur Acad Dermatol Venereol. 2014; 28(11):1553-9. DOI: 10.1111/jdv.12355. View

Blome C, Simianer S, Purwins S, Laass A, Rustenbach S, Schaefer I . Time needed for treatment is the major predictor of quality of life in psoriasis. Dermatology. 2010; 221(2):154-9. DOI: 10.1159/000313825. View

Sampogna F, Tabolli S, Soderfeldt B, Axtelius B, Aparo U, Abeni D . Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol. 2006; 154(5):844-9. DOI: 10.1111/j.1365-2133.2005.07071.x. View

Augustin M, Kruger K, Radtke M, Schwippl I, Reich K . Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology. 2008; 216(4):366-72. DOI: 10.1159/000119415. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010; 8(5):336-41. DOI: 10.1016/j.ijsu.2010.02.007. View

Augustin M, Holland B, Dartsch D, Langenbruch A, Radtke M . Adherence in the treatment of psoriasis: a systematic review. Dermatology. 2011; 222(4):363-74. DOI: 10.1159/000329026. View

Reich K, Mrowietz U . Treatment goals in psoriasis. J Dtsch Dermatol Ges. 2007; 5(7):566-74. DOI: 10.1111/j.1610-0387.2007.06343.x. View

10.

Langenbruch A, Radtke M, Augustin M . Quality of psoriasis care from the patients' perspective--results of the national health care study PsoReal. Eur J Dermatol. 2012; 22(4):518-24. DOI: 10.1684/ejd.2012.1740. View

11.

Jensen P, Ahlehoff O, Egeberg A, Gislason G, Hansen P, Skov L . Psoriasis and New-onset Depression: A Danish Nationwide Cohort Study. Acta Derm Venereol. 2015; 96(1):39-42. DOI: 10.2340/00015555-2183. View

12.

Hunter H, Griffiths C, Kleyn C . Does psychosocial stress play a role in the exacerbation of psoriasis?. Br J Dermatol. 2013; 169(5):965-74. DOI: 10.1111/bjd.12478. View

13.

Meyer B, Berger T, Caspar F, Beevers C, Andersson G, Weiss M . Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial. J Med Internet Res. 2009; 11(2):e15. PMC: 2762808. DOI: 10.2196/jmir.1151. View

14.

Blome C, Augustin M, Behechtnejad J, Rustenbach S . Dimensions of patient needs in dermatology: subscales of the patient benefit index. Arch Dermatol Res. 2010; 303(1):11-7. DOI: 10.1007/s00403-010-1073-0. View

15.

Mrowietz U, Elder J, Barker J . The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Arch Dermatol Res. 2006; 298(7):309-19. PMC: 1705513. DOI: 10.1007/s00403-006-0707-8. View

16.

Wohlrab J, Fiedler G, Gerdes S, Nast A, Philipp S, Radtke M . Recommendations for detection of individual risk for comorbidities in patients with psoriasis. Arch Dermatol Res. 2013; 305(2):91-8. DOI: 10.1007/s00403-013-1318-9. View

17.

Christophers E, Barker J, Griffiths C, Dauden E, Milligan G, Molta C . The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol. 2009; 24(5):548-54. DOI: 10.1111/j.1468-3083.2009.03463.x. View

18.

Reich A, Hrehorow E, Szepietowski J . Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol. 2010; 90(3):257-63. DOI: 10.2340/00015555-0851. View

19.

Chen Y, Xin T, Cheng A . Evaluating the effectiveness of psychological and/or educational interventions in psoriasis: a narrative review. J Dermatol. 2014; 41(9):775-8. DOI: 10.1111/1346-8138.12583. View

20.

Wu J, Penfold R, Primatesta P, Fox T, Stewart C, Reddy S . The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis. J Eur Acad Dermatol Venereol. 2017; 31(7):1168-1175. DOI: 10.1111/jdv.14175. View